Literature DB >> 17334927

MRI finding of simultaneous coexistence of growth hormone-secreting pituitary adenoma with intracranial meningioma and carotid artery aneurysms: report of a case.

Lorenzo Curto1, Stefano Squadrito, Barbara Almoto, Marcello Longo, Francesca Granata, Francesco Salpietro, Maria L Torre, Fiorella Marini, Francesco Trimarchi, Salvatore Cannavo.   

Abstract

Coexistence of pituitary adenoma, intracranial meningioma and cerebral aneurysm has never been described. We report on a patient with GH-secreting pituitary macroadenoma associated with a right frontal meningioma and with two intracavernous asymptomatic aneurisms. A 61-year-old woman was referred to our Endocrine Unit 13 years after a right frontal craniotomy for a pituitary tumour. Endocrine investigation showed high levels of IGF-1 (560 ng/ml) and increased basal serum GH (56 ng/ml) levels, not suppressed after OGTT. MRI showed persistence of a homogeneously enhancing intra- and suprasellar lesion, compressing the visual pathways, with bilateral intracavernous invasion and simultaneous coexistence of a right intracavernous internal carotid artery (ICA) aneurysm in direct contact with the pituitary tumour. Somatostatin analog treatment normalized GH and IGF-1 levels. Eight months later, the patient underwent a balloon ICA occlusion with disappearance of the right ICA aneurysm. One year later, a new MRI confirmed the presence of the pituitary mass showing also a right intracranial frontal meningioma and a new ICA aneurysm on the left side. Previous studies have suggested that prolonged GH hypersecretion could play a role in the genesis of intracranial aneurysms, inducing atherosclerotic and/or degenerative modification of the arterial walls. Other aetiological factors include a mechanical effect due to a direct contact between adenoma and aneurysm. Coexistence of pituitary adenoma and intracranial meningioma is a rare event, but also for this association it has been suggested that GH or other growth factors could play a role in appearance or in growth of meningioma. In our case, meningioma appeared and grew, despite the effective treatment of acromegaly.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17334927     DOI: 10.1007/s11102-007-0011-4

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  42 in total

Review 1.  Cardiovascular function in acromegaly.

Authors:  R N Clayton
Journal:  Endocr Rev       Date:  2003-06       Impact factor: 19.871

2.  Malignant intracranial neoplasms, following radiation therapy for acromegaly.

Authors:  M B GOLDBERG; G E SHELINE; N MALAMUD
Journal:  Radiology       Date:  1963-03       Impact factor: 11.105

Review 3.  Brain tumours: classification and genes.

Authors:  V P Collins
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-06       Impact factor: 10.154

4.  Immunohistochemical determination of five somatostatin receptors in meningioma reveals frequent overexpression of somatostatin receptor subtype sst2A.

Authors:  S Schulz; S U Pauli; S Schulz; M Händel; K Dietzmann; R Firsching; V Höllt
Journal:  Clin Cancer Res       Date:  2000-05       Impact factor: 12.531

5.  Chromosome 1p36 and 22qter deletions in paraffin block sections of intracranial meningiomas.

Authors:  Zerrin Yilmaz; Feride Iffet Sahin; Basar Atalay; Ozlem Ozen; Hakan Caner; Murad Bavbek; Beyhan Demirhan; Nur Altinörs
Journal:  Pathol Oncol Res       Date:  2005-12-31       Impact factor: 3.201

6.  [Association of acromegaly and a cerebral arterial aneurysm disclosed by a subarachnoid hemorrhage].

Authors:  M A Jaunsolo; M Aguirre; D Bellido; S Castro; M P Ruiz-Valdepenas; F G Hawkins
Journal:  Neurochirurgie       Date:  1986       Impact factor: 1.553

7.  Development of a meningioma in a patient with acromegaly during octreotide treatment: are there any causal relationships?

Authors:  E De Menis; G Tulipano; S Villa; D Billeci; C Bonfanti; P Pollara; P Pauletto; A Giustina
Journal:  J Endocrinol Invest       Date:  2003-04       Impact factor: 4.256

8.  Pituitary adenoma and meningioma in the same patient. Report of three cases.

Authors:  J Zentner; J Gilsbach
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

Review 9.  Multiple meningiomas and intracranial aneurysms: a case report and review of the literature.

Authors:  I M Ziyal; Y Aydin; G K Bejjani; A R Kaya; H Duman
Journal:  Acta Neurol Belg       Date:  1998-06       Impact factor: 2.396

10.  Somatostatin inhibits the activity of adenylate cyclase in cultured human meningioma cells and stimulates their growth.

Authors:  J W Koper; R Markstein; C Kohler; D J Kwekkeboom; C J Avezaat; S W Lamberts; J C Reubi
Journal:  J Clin Endocrinol Metab       Date:  1992-03       Impact factor: 5.958

View more
  23 in total

Review 1.  The management of the patient with acromegaly and headache: a still open clinical challenge.

Authors:  A Giustina; M Gola; A Colao; L De Marinis; M Losa; N Sicolo; E Ghigo
Journal:  J Endocrinol Invest       Date:  2008-10       Impact factor: 4.256

2.  Surgical treatment of brain tumor coexisted with intracranial aneurysm--case series and review of the literature.

Authors:  Zhihong Zhong; Yuhao Sun; Dong Lin; Qingfang Sun; Liuguan Bian
Journal:  Neurosurg Rev       Date:  2013-05-25       Impact factor: 3.042

3.  Prolactinoma associated with an ependymoma in the fourth ventricle: A case report and review of the literature.

Authors:  Jinlu Yu; Hongfa Yang; Limei Qu; Yunqian Li
Journal:  Oncol Lett       Date:  2015-05-12       Impact factor: 2.967

4.  Genetic analysis in a patient presenting with meningioma and familial isolated pituitary adenoma (FIPA) reveals selective involvement of the R81X mutation of the AIP gene in the pathogenesis of the pituitary tumor.

Authors:  Federica Guaraldi; Valentina Corazzini; Gary L Gallia; Silvia Grottoli; Karen Stals; Nadezhda Dalantaeva; Lawrence A Frohman; Márta Korbonits; Roberto Salvatori
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

5.  Prevalence of cerebral aneurysm in patients with acromegaly.

Authors:  Satoru Oshino; Akio Nishino; Tsuyoshi Suzuki; Hideyuki Arita; Akihiro Tateishi; Katsumi Matsumoto; Toshio Shimokawa; Manabu Kinoshita; Toshiki Yoshimine; Youichi Saitoh
Journal:  Pituitary       Date:  2013-06       Impact factor: 4.107

Review 6.  Giant Prolactinoma Embedded by Pseudoaneurysm of the Cavernous Carotid Artery Treated with a Tailored Therapeutic Scheme.

Authors:  Valeria Mercuri; Daniele Armocida; Francesco Paglia; Gargiulo Patrizia; Antonio Santoro; Luca D'Angelo
Journal:  J Neurosci Rural Pract       Date:  2022-07-04

7.  Coexistence of meningioma and other intracranial benign tumors in non-neurofibromatosis type 2 patients: A case report and review of literature.

Authors:  Tian-Hao Hu; Run Wang; Hai-Yun Wang; Yi-Fu Song; Juan-Han Yu; Zi-Xun Wang; Yu-Zhou Duan; Ting Liu; Sheng Han
Journal:  World J Clin Cases       Date:  2022-05-06       Impact factor: 1.534

Review 8.  Acromegaly: re-thinking the cancer risk.

Authors:  Siobhan Loeper; Shereen Ezzat
Journal:  Rev Endocr Metab Disord       Date:  2008-03       Impact factor: 6.514

Review 9.  Association of craniopharyngioma and pituitary adenoma.

Authors:  Federica Guaraldi; Nunzia Prencipe; Valentina di Giacomo; Massimo Scanarini; Valentina Gasco; Marina Paola Gardiman; Alessandro M Berton; Ezio Ghigo; Silvia Grottoli
Journal:  Endocrine       Date:  2013-02-02       Impact factor: 3.633

10.  Simultaneous occurrence of cerebellar medulloblastoma and pituitary adenoma: A case report.

Authors:  Vassilis Samaras; Efstathios Samaras; Ioanna Stergiou; Paraskevi Konstantopoulou; Christos Arnaoutoglou; Marianthi Arnaoutoglou; Vassilis Varsos; Calypso Barbatis
Journal:  Cases J       Date:  2008-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.